Avsar.

Healthcare · Pharmaceuticals

SMS Pharmaceuticals Ltd (SMSPHARMA)

₹381.10

Mkt cap
₹3,526 Cr
P/E ratio
34.60
P/B
4.54
Div yield
0.11%
ROE
14.30%
ROCE
13.30%
EPS (TTM)
₹11.01
Book value
₹84
52W range
215–438
Sector
Healthcare

SMS Pharmaceuticals Ltd is a diversified and integrated pharmaceutical company with interests in Active Pharmaceutical Ingredients (API) and Intermediates. [1]

NSE SMSPHARMABSE 532815www.smspharma.com
Health check
Mixed
ValuationFair
ProfitabilityAverage
GrowthModerate
TechnicalsNeutral
52-week range
−13.05% from high
₹381
₹215+77.50% from low₹438
Current
₹381.10
Prev close
₹385.95
Day
−1.26%
Price performance
1D
−1.26%
1W
−0.87%
1M
+1.21%
3M
−3.93%
6M
+23.07%
1Y
+53.73%
YTD
+16.81%

Financials

F
Revenue, profit & margin
P/E ratio
34.6×
SMSPHARMA is 4% above the sector median of 33.3×
SMSPHARMA34.6×
Sector median33.3×
 Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Trend
Sales149135167161246164197173248196242210238
Expenses126109139132212131165140207157194167198
Operating Profit23262829343431334139484440
OPM %16%19%17%18%14%20%16%19%16%20%20%21%17%
Other Income1111211211143
Interest6666655456665
Depreciation88888899910101010
Profit before tax11131517222220222924343127
Tax %24%31%21%26%26%25%29%24%30%23%26%26%23%
Net Profit691211171614182020252333
EPS in Rs0.731.101.381.362.041.951.662.152.292.312.702.513.49
Raw PDF

Earnings

EResults dates & reactions
No upcoming results date on calendar.

Fresh quarters land in the Financials table above, tagged NSE until screener catches up.

No reaction history yet.
No quarterly filings ingested yet.

Corporate actions

CLast 6 months

No recent corporate actions

Dividends, splits, and bonuses in the last six months show up here.

Shareholding

Sas of Mar 2026
68.07%Promoter
Promoters68.07%
FIIs0.31%0.27
DIIs3.02%0.19
Public28.60%0.09
Ownership trend

Peers

P8 companies
Valuation vs quality
P/E × ROCE · bubble = market cap
NameCMPP/EMkt CapDiv YldNP QtrQtr Profit VarSales QtrQtr Sales VarROCE
Sun Pharma.Inds.₹1,862.8035.824,46,9480.86%2,710+13.58%14,612+12.76%20.53%
Divi's Lab.₹6,713.5067.941,78,2220.45%751+13.44%2,831+9.52%21.96%
Torrent Pharma.₹4,516.2069.741,52,8490.84%364−20.58%4,197+41.84%15.19%
Cipla₹1,440.1030.561,16,3380.90%543−54.61%6,541−2.80%15.49%
Dr Reddy's Labs₹1,350.5026.861,12,7230.59%221−86.14%7,546−11.51%13.64%
Zydus Lifesci.₹1,101.4020.431,10,8270.09%1,341+21.92%7,587+16.22%21.15%
Lupin₹2,343.5018.591,07,1520.51%1,469+101.49%7,475+31.89%30.32%
SMS Pharma.₹376.5534.583,5260.11%33+60.97%238−4.13%13.30%
Median: 157 Co.₹408.3033.251,7980.09%12+22.34%177+16.22%15.14%

Filings

D
Annual reports15
Financial Year 2025bseFinancial Year 2024bseFinancial Year 2023bseFinancial Year 2022bseFinancial Year 2021bseFinancial Year 2020bseFinancial Year 2019bseFinancial Year 2018bseFinancial Year 2017bseFinancial Year 2016bseFinancial Year 2015bseFinancial Year 2014bseFinancial Year 2013bseFinancial Year 2012bseFinancial Year 2011nse
Concall transcripts38
TranscriptPPTPPTTranscriptPPTRECPPTTranscriptPPTPPTTranscriptPPTTranscriptPPTTranscriptPPTTranscriptPPTTranscriptPPTTranscriptPPTRECTranscript
Credit ratings6
Rating update 4 Dec 2025careRating update 10 Oct 2024careRating update 7 Dec 2023careRating update 3 Nov 2022careRating update 3 Oct 2022careRating update 3 Sep 2021care
Announcements5
Closure of Trading Window 2d - Trading window closed1 July 2026 until 48 hours after Q1 FY26 results.Disclosure Under Regulation 30 Of The SEBI (LODR) Regulations, 2015. 5 Jun - 85,000 physical shares of 7 shareholders fraudulently claimed; complaint filed with Hyderabad EOW.Announcement under Regulation 30 (LODR)-Earnings Call Transcript 30 May - Transcripts of the Conference call held on 27th May, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome 27 May - Audio recording of investor call on Q4 and FY2026 audited results uploaded on company website.Announcement under Regulation 30 (LODR)-Newspaper Publication 25 May